OpenRegistry
Companies House/Tollhouse Hill/Company profile

CATALYST CLINICAL RESEARCH EUROPE, LTD.

Active
08872035·incorporated 2014-01-31

CATALYST CLINICAL RESEARCH EUROPE, LTD. is an active UK private limited company, incorporated on 31 January 2014 at Companies House (number 08872035; OpenRegistry canonical ID GB-08872035-catalyst-clinical-research-europe-ltd). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,208 active UK entities in that code and one of 1 active companies registered in Tollhouse Hill, Nottingham (postcode NG1). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2014-01-31
Registered Address
4TH FLOOR, EAST WEST, TOLLHOUSE HILL, NOTTINGHAM, NG1 5FS, UNITED KINGDOM
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Directors

Search directors of CATALYST CLINICAL RESEARCH EUROPE, LTD.

Shareholders

Look up shareholders of CATALYST CLINICAL RESEARCH EUROPE, LTD.

Financials

Check financials of CATALYST CLINICAL RESEARCH EUROPE, LTD.

Filings

Check filing history of CATALYST CLINICAL RESEARCH EUROPE, LTD.

Accounts

Last filed accounts made up to 2024-12-31. Next accounts due 2026-09-30. Financial year-end: 31/12. Filing class: MEDIUM.

Confirmation statement

Last confirmation statement made up to 2026-01-21. Next confirmation statement due 2027-02-04.

Mortgages and charges

4 charges recorded against the company at Companies House: 0 outstanding, 4 satisfied, 0 partially satisfied.

Persons with significant control

  • No individual or entity with significant control has been identified.

4 historical PSC records have ceased:

  • Mr Jonathan Lewis born 1962 resident in England, British national. Notified 2016-04-06. Ceased 2022-04-29.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Mr Stephen Mcconchie born 1964 resident in United Kingdom, British national. Notified 2016-04-06. Ceased 2022-04-29.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Project Constellation Holdings, Inc. (United States reg. 1763160). Notified 2022-04-29. Ceased 2022-09-12.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Catalyst Clinical Research, Llc (United States reg. 1376420). Notified 2022-04-29. Ceased 2022-09-22.
    • Owns 75% or more of shares
    • Holds 50–75% of voting rights
    • Significant Influence Or Control As Firm

Previous names

CATALYST CLINICAL RESEARCH EUROPE, LTD. has previously traded as:

  • APTUS CLINICAL LIMITED (until 2023-04-27)

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Need real-time profile, officers, shareholders, financials or filing? Open the live profile at /company/gb/08872035.

Source: Companies House Free Company Data, refreshed 2026-06-06. Official record: find-and-update.company-information.service.gov.uk.